Creative Planning Geron Corp Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Geron Corp stock. As of the latest transaction made, Creative Planning holds 92,784 shares of GERN stock, worth $370,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,784

Previous 74,947 23.8%

Holding current value

$370,208

Previous $317,000 32.81%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$4.17 - $4.99 $74,380 - $89,006	17,837 Added 23.8%	92,784 $421,000
Q2 2024 Aug 15, 2024	BUY	$3.1 - $5.09 $123,748 - $203,187	39,919 Added 113.96%	74,947 $317,000
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $10,869 - $21,365	6,211 Added 21.55%	35,028 $115,000
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $28,570 - $37,930	16,420 Added 132.45%	28,817 $60,000
Q3 2023 Nov 16, 2023	BUY	$2.11 - $3.28 $26,157 - $40,662	12,397 New	12,397 $26,000
Q2 2021 Aug 04, 2021	SELL	$1.25 - $1.83 $242,828 - $355,501	-194,263 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.52 - $2.1 $121,600 - $168,000	80,000 Added 70.01%	194,263 $307,000
Q4 2020 Jan 29, 2021	SELL	$1.55 - $2.05 $1,190 - $1,574	-768 Reduced 0.67%	114,263 $182,000
Q3 2020 Nov 05, 2020	BUY	$1.59 - $2.19 $16,933 - $23,323	10,650 Added 10.2%	115,031 $200,000
Q2 2020 Jul 23, 2020	BUY	$1.05 - $2.18 $20,895 - $43,382	19,900 Added 23.56%	104,381 $228,000
Q1 2020 May 05, 2020	SELL	$0.89 - $1.49 $17,800 - $29,800	-20,000 Reduced 19.14%	84,481 $101,000
Q4 2019 Jan 30, 2020	SELL	$1.27 - $1.54 $889 - $1,078	-700 Reduced 0.67%	104,481 $142,000
Q3 2019 Nov 01, 2019	SELL	$1.15 - $1.59 $15,927 - $22,021	-13,850 Reduced 11.64%	105,181 $140,000
Q2 2019 Jul 26, 2019	BUY	$1.37 - $2.02 $163,072 - $240,442	119,031 New	119,031 $168,000
Q4 2018 Feb 01, 2019	SELL	$0.98 - $1.85 $311,650 - $588,320	-318,011 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$1.76 - $6.38 $2,288 - $8,294	-1,300 Reduced 0.41%	318,011 $560,000
Q2 2018 Jul 20, 2018	BUY	$3.29 - $4.82 $365,874 - $536,022	111,208 Added 53.44%	319,311 $1.1 Million
Q1 2018 Apr 18, 2018	SELL	$1.81 - $5.98 $181,760 - $600,511	-100,420 Reduced 32.55%	208,103 $884,000
Q4 2017 Jan 17, 2018	BUY	$1.8 - $2.32 $228,258 - $294,199	126,810 Added 69.79%	308,523 $555,000
Q3 2017 Oct 17, 2017	BUY	$1.99 - $2.65 $361,608 - $481,539	181,713	181,713 $396,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Geron Corp Transaction History